Characteristics of Early MRI in Children and Adolescents with Vanishing White Matter
10 October 2011
23 December 2011
19 March 2012 (online)
Objective MRI in vanishing white matter typically shows diffuse abnormality of the cerebral white matter, which becomes increasingly rarefied and cystic. We investigated the MRI characteristics preceding this stage.
Design In a retrospective observational study, we evaluated all available MRIs in our database of DNA-confirmed VWM patients and selected MRIs without diffuse cerebral white matter abnormalities and without signs of rarefaction or cystic degeneration in patients below 20 years of age. A previously established scoring list was used to evaluate the MRIs.
Results An MRI of seven patients fulfilled the criteria. All had confluent and symmetrical abnormalities in the periventricular and bordering deep white matter. In young patients, myelination was delayed. The inner rim of the corpus callosum was affected in all patients.
Conclusions In early stages of VWM, MRI does not necessarily display diffuse cerebral white matter involvement and rarefaction or cystic degeneration. If the MRI abnormalities do not meet the criteria for VWM, it helps to look at the corpus callosum. If the inner rim (the callosal-septal interface) is affected, VWM should be considered.
- 1 Schiffmann R, Moller JR, Trapp BD , et al. Childhood ataxia with diffuse central nervous system hypomyelination. Ann Neurol 1994; 35 (3) 331-340
- 2 van der Knaap MS, Barth PG, Gabreëls FJ , et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997; 48 (4) 845-855
- 3 Vermeulen G, Seidl R, Mercimek-Mahmutoglu S, Rotteveel JJ, Scheper GC, van der Knaap MS. Fright is a provoking factor in vanishing white matter disease. Ann Neurol 2005; 57 (4) 560-563
- 4 Fogli A, Schiffmann R, Bertini E , et al. The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 2004; 62 (9) 1509-1517
- 5 Labauge P, Horzinski L, Ayrignac X , et al. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 2009; 132 (Pt 8) 2161-2169
- 6 van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 1998; 51 (2) 540-547
- 7 van der Knaap MS, van Berkel CG, Herms J , et al. eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet 2003; 73 (5) 1199-1207
- 8 van der Knaap MS, Leegwater PA, Könst AA , et al. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol 2002; 51 (2) 264-270
- 9 van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol 2006; 5 (5) 413-423
- 10 van der Knaap MS, Breiter SN, Naidu S, Hart AA, Valk J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 1999; 213 (1) 121-133
- 11 Shioda M, Hayashi M, Takanashi J, Osawa M. Lesions in the central tegmental tract in autopsy cases of developmental brain disorders. Brain Dev 2011; 33 (7) 541-547
- 12 Tenembaum S, Chitnis T, Ness J, Hahn JS ; International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology 2007; 68 (16, Suppl 02) S23 –S36
- 13 Tunkel AR, Glaser CA, Bloch KC , et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47 (3) 303-327
- 14 van der Lei HD, Steenweg ME, Bugiani M , et al. Restricted diffusion in vanishing white matter. Arch Neurol 2012; ; February 6 (Epub ahead of print)
- 15 Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008; 8 (5-6) 396-413
- 16 van der Knaap MS, Valk J . Magnetic resonance of myelination and myelin disorders. 3rd edition. Springer, Heidelberg, 2005
- 17 van der Knaap MS, Leegwater PA, van Berkel CG , et al. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults. Neurology 2004; 62 (9) 1598-1600
- 18 van der Knaap MS, Wevers RA, Kure S , et al. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol 1999; 14 (11) 728-731
- 19 Vanderver A, Schiffmann R, Timmons M , et al. Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. Clin Chem 2005; 51 (11) 2031-2042